-
1
-
-
0027503277
-
Protein analysis in cerebrospinal fluid: II. Reference values derived from healthy individuals 18-88 years of age
-
Blennow K, Fredman P, Wallin A et al (1993) Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age. Eur Neurol 33:129-133 (Pubitemid 23100537)
-
(1993)
European Neurology
, vol.33
, Issue.2
, pp. 129-133
-
-
Blennow, K.1
Fredman, P.2
Wallin, A.3
Gottfries, C.-G.4
Karlsson, I.5
Langstrom, G.6
Skoog, I.7
Svennerholm, L.8
Wikkelso, C.9
-
2
-
-
0029609264
-
tau Protein in cerebrospinal fluid: A biochemical marker for axonal degeneration in Alzheimer disease?
-
Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E (1995) Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Mol Chem Neuropathol 26:231-245. doi:10.1007/BF02815140 (Pubitemid 26002016)
-
(1995)
Molecular and Chemical Neuropathology
, vol.26
, Issue.3
, pp. 231-245
-
-
Blennow, K.1
Wallin, A.2
Agren, H.3
Spenger, C.4
Siegfried, J.5
Vanmechelen, E.6
-
3
-
-
79959772357
-
Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance
-
doi:10.1126/scitranslmed.3002156
-
Castellano JM, Kim J, Stewart FR et al (2011) Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci Transl Med 3:89ra57. doi:10.1126/scitranslmed.3002156
-
(2011)
Sci Transl Med
, vol.3
-
-
Castellano, J.M.1
Kim, J.2
Stewart, F.R.3
-
4
-
-
0028305380
-
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
-
DOI 10.1038/ng0694-180
-
Corder EH, Saunders AM, Risch NJ et al (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 7:180-184 (Pubitemid 24174658)
-
(1994)
Nature Genetics
, vol.7
, Issue.2
, pp. 180-184
-
-
Corder, E.H.1
Saunders, A.M.2
Risch, N.J.3
Strittmatter, W.J.4
Schmechel, D.E.5
Gaskell Jr., P.C.6
Rimmler, J.B.7
Locke, P.A.8
Conneally, P.M.9
Schmader, K.E.10
Small, G.W.11
Roses, A.D.12
Haines, J.L.13
Pericak-Vance, M.A.14
-
5
-
-
84862777666
-
ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models
-
doi:10.1126/science.1217697
-
Cramer PE, Cirrito JR, Wesson DW et al (2012) ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models. Science 335:1503-1506. doi:10.1126/science.1217697
-
(2012)
Science
, vol.335
, pp. 1503-1506
-
-
Cramer, P.E.1
Cirrito, J.R.2
Wesson, D.W.3
-
6
-
-
84867119124
-
Cerebrospinal fluid APOE levels: An endophenotype for genetic studies for Alzheimer's disease
-
doi:10.1093/hmg/dds296
-
Cruchaga C, Kauwe JS, Nowotny P et al (2012) Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease. Hum Mol Genet 21:4558-4571. doi:10.1093/hmg/dds296
-
(2012)
Hum Mol Genet
, vol.21
, pp. 4558-4571
-
-
Cruchaga, C.1
Kauwe, J.S.2
Nowotny, P.3
-
7
-
-
80053646543
-
Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo
-
doi:10.1016/j.neurobiolaging.2010.04.028
-
Darreh-Shori T, Forsberg A, Modiri N et al (2011) Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo. Neurobiol Aging 32(2320):e2315-e2332. doi:10.1016/j.neurobiolaging.2010.04.028
-
(2011)
Neurobiol Aging
, vol.32
, Issue.2320
-
-
Darreh-Shori, T.1
Forsberg, A.2
Modiri, N.3
-
8
-
-
33644832047
-
42 in humans
-
DOI 10.1002/ana.20730
-
Fagan AM, Mintun MA, Mach RH et al (2006) Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol 59:512-519. doi:10.1002/ana.20730 (Pubitemid 43358072)
-
(2006)
Annals of Neurology
, vol.59
, Issue.3
, pp. 512-519
-
-
Fagan, A.M.1
Mintun, M.A.2
Mach, R.H.3
Lee, S.-Y.4
Dence, C.S.5
Shah, A.R.6
LaRossa, G.N.7
Spinner, M.L.8
Klunk, W.E.9
Mathis, C.A.10
DeKosky, S.T.11
Morris, J.C.12
Holtzman, D.M.13
-
9
-
-
0030823158
-
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A meta-analysis
-
Farrer LA, Cupples LA, Haines JL et al (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta analysis consortium. JAMA 278:1349-1356 (Pubitemid 27449696)
-
(1997)
Journal of the American Medical Association
, vol.278
, Issue.16
, pp. 1349-1356
-
-
Farrer, L.A.1
Cupples, L.A.2
Haines, J.L.3
Hyman, B.4
Kukull, W.A.5
Mayeux, R.6
Myers, R.H.7
Pericak-Vance, M.A.8
Risch, N.9
Van Duijn, C.M.10
-
10
-
-
0022449937
-
4 in humans
-
Gregg RE, Zech LA, Schaefer EJ, Stark D, Wilson D, Brewer HB Jr (1986) Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest 78:815-821. doi:10.1172/JCI112645 (Pubitemid 16024820)
-
(1986)
Journal of Clinical Investigation
, vol.78
, Issue.3
, pp. 815-821
-
-
Gregg, R.E.1
Zech, L.A.2
Schaefer, E.J.3
-
11
-
-
79953193799
-
Plasma apolipoprotein E and Alzheimer disease risk: The AIBL study of aging
-
doi:10.1212/WNL.0b013e318211c352
-
Gupta VB, Laws SM, Villemagne VL et al (2011) Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging. Neurology 76:1091-1098. doi:10.1212/WNL.0b013e318211c352
-
(2011)
Neurology
, vol.76
, pp. 1091-1098
-
-
Gupta, V.B.1
Laws, S.M.2
Villemagne, V.L.3
-
12
-
-
33746311471
-
Apolipoprotein E structure: Insights into function
-
DOI 10.1016/j.tibs.2006.06.008, PII S0968000406001708
-
Hatters DM, Peters-Libeu CA, Weisgraber KH (2006) Apolipoprotein E structure: insights into function. Trends Biochem Sci 31:445-454. doi:10.1016/j.tibs.2006.06.008 (Pubitemid 44108662)
-
(2006)
Trends in Biochemical Sciences
, vol.31
, Issue.8
, pp. 445-454
-
-
Hatters, D.M.1
Peters-Libeu, C.A.2
Weisgraber, K.H.3
-
13
-
-
58549109632
-
Plasma lipoproteins: Genetic influences and clinical implications
-
doi:10.1038/nrg2481
-
Hegele RA (2009) Plasma lipoproteins: genetic influences and clinical implications. Nat Rev Genet 10:109-121. doi:10.1038/nrg2481
-
(2009)
Nat Rev Genet
, vol.10
, pp. 109-121
-
-
Hegele, R.A.1
-
14
-
-
0025257612
-
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI
-
Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545-548 (Pubitemid 20107994)
-
(1990)
Journal of Lipid Research
, vol.31
, Issue.3
, pp. 545-548
-
-
Hixson, J.E.1
Vernier, D.T.2
-
15
-
-
84890365334
-
Gene transfer of human apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain
-
doi:10.1126/scitranslmed.3007000
-
Hudry E, Dashkoff J, Roe AD et al (2013) Gene transfer of human apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain. Sci Transl Med 5:212ra161. doi:10.1126/ scitranslmed.3007000
-
(2013)
Sci Transl Med
, vol.5
-
-
Hudry, E.1
Dashkoff, J.2
Roe, A.D.3
-
16
-
-
67650094927
-
Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age
-
doi:10.1002/ana.21696
-
Kok E, Haikonen S, Luoto T et al (2009) Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age. Ann Neurol 65:650-657. doi:10.1002/ana.21696
-
(2009)
Ann Neurol
, vol.65
, pp. 650-657
-
-
Kok, E.1
Haikonen, S.2
Luoto, T.3
-
17
-
-
84878816554
-
Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice
-
doi:10.1186/1750-1326-8-18
-
LaClair KD, Manaye KF, Lee DL et al (2013) Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice. Mol Neurodegener 8:18. doi:10.1186/1750-1326-8-18
-
(2013)
Mol Neurodegener
, vol.8
, pp. 18
-
-
LaClair, K.D.1
Manaye, K.F.2
Lee, D.L.3
-
18
-
-
0035864632
-
Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study
-
DOI 10.1016/S0021-9150(00)00570-0, PII S0021915000005700
-
Lahoz C, Schaefer EJ, Cupples LA et al (2001) Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis 154:529-537. doi:10.1016/S0021-9150(00)00570-0 (Pubitemid 32232149)
-
(2001)
Atherosclerosis
, vol.154
, Issue.3
, pp. 529-537
-
-
Lahoz, C.1
Schaefer, E.J.2
Cupples L.Adrienne3
Wilson, P.W.F.4
Levy, D.5
Osgood, D.6
Parpos, S.7
Pedro-Botet, J.8
Daly, J.A.9
Ordovas, J.M.10
-
19
-
-
0025878638
-
Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation
-
doi:10.1172/JCI115288
-
Linton MF, Gish R, Hubl ST et al (1991) Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J Clin Invest 88:270-281. doi:10.1172/JCI115288
-
(1991)
J Clin Invest
, vol.88
, pp. 270-281
-
-
Linton, M.F.1
Gish, R.2
Hubl, S.T.3
-
20
-
-
84873722367
-
Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy
-
doi:10.1038/nrneurol.2012.263
-
Liu CC, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9:106-118. doi:10.1038/nrneurol.2012.263
-
(2013)
Nat Rev Neurol
, vol.9
, pp. 106-118
-
-
Liu, C.C.1
Kanekiyo, T.2
Xu, H.3
Bu, G.4
-
21
-
-
84868352782
-
Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from mice
-
doi:10.1152/ajpregu.00219.2012
-
Liu M, Kuhel DG, Shen L, Hui DY, Woods SC (2012) Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from mice. Am J Physiol Regul Integr Comp Physiol 303:R903-R908. doi:10.1152/ajpregu.00219.2012
-
(2012)
Am J Physiol Regul Integr Comp Physiol
, vol.303
-
-
Liu, M.1
Kuhel, D.G.2
Shen, L.3
Hui, D.Y.4
Woods, S.C.5
-
22
-
-
84876894324
-
Binding of apolipoprotein E inhibits the oligomer growth of amyloid-beta peptide in solution as determined by fluorescence cross-correlation spectroscopy
-
doi:10.1074/jbc.M112.411900
-
Ly S, Altman R, Petrlova J et al (2013) Binding of apolipoprotein E inhibits the oligomer growth of amyloid-beta peptide in solution as determined by fluorescence cross-correlation spectroscopy. J Biol Chem 288:11628-11635. doi:10.1074/jbc.M112.411900
-
(2013)
J Biol Chem
, vol.288
, pp. 11628-11635
-
-
Ly, S.1
Altman, R.2
Petrlova, J.3
-
23
-
-
0034575124
-
Apolipoprotein E: Far more than a lipid transport protein
-
doi:10.1146/annurev.genom.1.1.507
-
Mahley RW, Rall SC Jr (2000) Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1:507-537. doi:10.1146/annurev. genom.1.1.507
-
(2000)
Annu Rev Genomics Hum Genet
, vol.1
, pp. 507-537
-
-
Mahley, R.W.1
Rall Jr., S.C.2
-
24
-
-
66349085616
-
Apolipoprotein E: Structure determines function, from atherosclerosis to Alzheimer's disease to AIDS
-
doi:10.1194/jlr.R800069-JLR200
-
Mahley RW, Weisgraber KH, Huang Y (2009) Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. J Lipid Res 50(Suppl):S183-S188. doi:10.1194/jlr.R800069-JLR200
-
(2009)
J Lipid Res
, vol.50
, Issue.SUPPL.
-
-
Mahley, R.W.1
Weisgraber, K.H.2
Huang, Y.3
-
25
-
-
84893826356
-
Assessment of Peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e isoforms
-
doi:10.1021/pr401060x
-
Martinez-Morillo E, Nielsen HM, Batruch I et al (2014) Assessment of Peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e isoforms. J Proteome Res 13:1077-1087. doi:10.1021/pr401060x
-
(2014)
J Proteome Res
, vol.13
, pp. 1077-1087
-
-
Martinez-Morillo, E.1
Nielsen, H.M.2
Batruch, I.3
-
26
-
-
0021271971
-
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
-
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944 (Pubitemid 14076461)
-
(1984)
Neurology
, vol.34
, Issue.7
, pp. 939-944
-
-
McKhann, G.1
Drachman, D.2
Folstein, M.3
-
28
-
-
33745584625
-
ApoE plasma levels and risk of cardiovascular mortality in old age
-
doi:10.1371/journal.pmed.0030176
-
Mooijaart SP, Berbee JF, van Heemst D et al (2006) ApoE plasma levels and risk of cardiovascular mortality in old age. PLoS Med 3: e176. doi:10.1371/journal.pmed.0030176
-
(2006)
PLoS Med
, vol.3
-
-
Mooijaart, S.P.1
Berbee, J.F.2
Van Heemst, D.3
-
29
-
-
84893736391
-
Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitro
-
doi:10.1002/glia.22619
-
Mulder SD, Nielsen HM, Blankenstein MA, Eikelenboom P, Veerhuis R (2014) Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitro. Glia 62:493-503. doi:10.1002/glia.22619
-
(2014)
Glia
, vol.62
, pp. 493-503
-
-
Mulder, S.D.1
Nielsen, H.M.2
Blankenstein, M.A.3
Eikelenboom, P.4
Veerhuis, R.5
-
30
-
-
77954375412
-
Astrocytic A beta 1-42 uptake is determined by A beta-aggregation state and the presence of amyloid-associated proteins
-
doi:10.1002/glia.21004
-
Nielsen HM, Mulder SD, Belien JA, Musters RJ, Eikelenboom P, Veerhuis R (2010) Astrocytic A beta 1-42 uptake is determined by A beta-aggregation state and the presence of amyloid-associated proteins. Glia 58:1235-1246. doi:10.1002/glia.21004
-
(2010)
Glia
, vol.58
, pp. 1235-1246
-
-
Nielsen, H.M.1
Mulder, S.D.2
Belien, J.A.3
Musters, R.J.4
Eikelenboom, P.5
Veerhuis, R.6
-
31
-
-
58149251844
-
Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels
-
Riddell DR, Zhou H, Atchison K et al (2008) Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels. J Neurosci 28:11445-11453
-
(2008)
J Neurosci
, vol.28
, pp. 11445-11453
-
-
Riddell, D.R.1
Zhou, H.2
Atchison, K.3
-
32
-
-
84879083786
-
Fluid biomarkers in Alzheimer's disease-current concepts
-
doi:10.1186/1750-1326-8-20
-
Rosen C, Hansson O, Blennow K, Zetterberg H (2013) Fluid biomarkers in Alzheimer's disease-current concepts. Mol Neurodegener 8:20. doi:10.1186/1750-1326-8-20
-
(2013)
Mol Neurodegener
, vol.8
, pp. 20
-
-
Rosen, C.1
Hansson, O.2
Blennow, K.3
Zetterberg, H.4
-
33
-
-
0028026587
-
Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3
-
doi:10.1172/JCI117407
-
Sanan DA, Weisgraber KH, Russell SJ et al (1994) Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. J Clin Invest 94:860-869. doi:10.1172/JCI117407
-
(1994)
J Clin Invest
, vol.94
, pp. 860-869
-
-
Sanan, D.A.1
Weisgraber, K.H.2
Russell, S.J.3
-
34
-
-
84896705296
-
Cerebrospinal fluid apolipoprotein e concentration and severity of cognitive impairment in patients with newly diagnosed Alzheimer's disease
-
doi:10.1177/1533317513505133
-
Schmidt C, Becker H, Zerr I (2014) Cerebrospinal fluid apolipoprotein e concentration and severity of cognitive impairment in patients with newly diagnosed Alzheimer's disease. Am J Alzheimers Dis Other Demen 29:54-60. doi:10.1177/1533317513505133
-
(2014)
Am J Alzheimers Dis Other Demen
, vol.29
, pp. 54-60
-
-
Schmidt, C.1
Becker, H.2
Zerr, I.3
-
35
-
-
84876672025
-
Brain regional correlation of amyloid-beta with synapses and apolipoprotein E in non-demented individuals: Potential mechanisms underlying regional vulnerability to amyloid-beta accumulation
-
doi:10.1007/s00401-013-1086-9
-
Shinohara M, Petersen RC, Dickson DW, Bu G (2013) Brain regional correlation of amyloid-beta with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-beta accumulation. Acta Neuropathol 125:535-547. doi:10.1007/s00401-013- 1086-9
-
(2013)
Acta Neuropathol
, vol.125
, pp. 535-547
-
-
Shinohara, M.1
Petersen, R.C.2
Dickson, D.W.3
Bu, G.4
-
36
-
-
84869217993
-
Total ApoE and ApoE4 isoform assays in an Alzheimer's disease case-control study by targeted mass spectrometry (n = 669): A pilot assay for methionine-containing proteotypic peptides
-
doi:10.1074/mcp.M112.018861
-
Simon R, Girod M, Fonbonne C et al (2012) Total ApoE and ApoE4 isoform assays in an Alzheimer's disease case-control study by targeted mass spectrometry (n = 669): a pilot assay for methionine-containing proteotypic peptides. Mol Cell Proteomics 11:1389-1403. doi:10.1074/mcp.M112.018861
-
(2012)
Mol Cell Proteomics
, vol.11
, pp. 1389-1403
-
-
Simon, R.1
Girod, M.2
Fonbonne, C.3
-
37
-
-
10044243556
-
Apolipoprotein E and cognitive performance: A meta-analysis
-
DOI 10.1037/0882-7974.19.4.592
-
Small BJ, Rosnick CB, Fratiglioni L, Backman L (2004) Apolipoprotein E and cognitive performance: a meta-analysis. Psychol Aging 19:592-600. doi:10.1037/0882-7974.19.4.592 (Pubitemid 39603405)
-
(2004)
Psychology and Aging
, vol.19
, Issue.4
, pp. 592-600
-
-
Small, B.J.1
Rosnick, C.B.2
Fratiglioni, L.3
Backman, L.4
-
38
-
-
0023775474
-
Apolipoprotein E polymorphism in The Netherlands and its effect on plasma lipid and apolipoprotein levels
-
Smit M, de Knijff P, Rosseneu M et al (1988) Apolipoprotein E polymorphism in The Netherlands and its effect on plasma lipid and apolipoprotein levels. Hum Genet 80:287-292
-
(1988)
Hum Genet
, vol.80
, pp. 287-292
-
-
Smit, M.1
De Knijff, P.2
Rosseneu, M.3
-
39
-
-
84862174192
-
Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals
-
doi:10.1371/journal.pone.0034078
-
Song F, Poljak A, Crawford J et al (2012) Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals. PLoS ONE 7:e34078. doi:10.1371/journal.pone.0034078
-
(2012)
PLoS ONE
, vol.7
-
-
Song, F.1
Poljak, A.2
Crawford, J.3
-
40
-
-
84899905643
-
CSF Apo-E levels associate with cognitive decline and MRI changes
-
doi:10.1007/s00401-013-1236-0
-
Toledo JB, Da X, Weiner MW et al (2014) CSF Apo-E levels associate with cognitive decline and MRI changes. Acta Neuropathol. doi:10.1007/s00401-013- 1236-0
-
(2014)
Acta Neuropathol
-
-
Toledo, J.B.1
Da, X.2
Weiner, M.W.3
-
41
-
-
84874045326
-
APOE epsilon4 increases risk for dementia in pure synucleinopathies
-
doi:10.1001/jamaneurol.2013.600
-
Tsuang D, Leverenz JB, Lopez OL et al (2013) APOE epsilon4 increases risk for dementia in pure synucleinopathies. JAMA Neurol 70:223-228. doi:10.1001/jamaneurol.2013.600
-
(2013)
JAMA Neurol
, vol.70
, pp. 223-228
-
-
Tsuang, D.1
Leverenz, J.B.2
Lopez, O.L.3
-
42
-
-
77953248905
-
Formation and function of apolipoprotein E-containing lipoproteins in the nervous system
-
doi:10.1016/j.bbalip.2010.02.007
-
Vance JE, Hayashi H (2010) Formation and function of apolipoprotein E-containing lipoproteins in the nervous system. Biochim Biophys Acta 1801:806-818. doi:10.1016/j.bbalip.2010.02.007
-
(2010)
Biochim Biophys Acta
, vol.1801
, pp. 806-818
-
-
Vance, J.E.1
Hayashi, H.2
-
43
-
-
0033637408
-
Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma
-
Vanderstichele H, Van Kerschaver E, Hesse C et al (2000) Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma. Amyloid 7:245-258
-
(2000)
Amyloid
, vol.7
, pp. 245-258
-
-
Vanderstichele, H.1
Van Kerschaver, E.2
Hesse, C.3
-
44
-
-
0034607960
-
Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: A sandwich ELISA with a synthetic phosphopeptide for standardization
-
DOI 10.1016/S0304-3940(00)01036-3, PII S0304394000010363
-
Vanmechelen E, Vanderstichele H, Davidsson P et al (2000) Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neurosci Lett 285:49-52. doi:10.1016/S0304-3940(00)01036-3 (Pubitemid 30224621)
-
(2000)
Neuroscience Letters
, vol.285
, Issue.1
, pp. 49-52
-
-
Vanmechelen, E.1
Vanderstichele, H.2
Davidsson, P.3
Van Kerschaver, E.4
Van Der, P.B.5
Sjogren, M.6
Andreasen, N.7
Blennow, K.8
-
46
-
-
79951713725
-
Apolipoprotein E in Alzheimer's disease and other neurological disorders
-
doi:10.1016/S1474-4422(10)70325-2
-
Verghese PB, Castellano JM, Holtzman DM (2011) Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol 10:241-252. doi:10.1016/S1474-4422(10)70325-2
-
(2011)
Lancet Neurol
, vol.10
, pp. 241-252
-
-
Verghese, P.B.1
Castellano, J.M.2
Holtzman, D.M.3
-
47
-
-
84877326649
-
ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE/Abeta association in physiological conditions
-
doi:10.1073/pnas.1220484110
-
Verghese PB, Castellano JM, Garai K et al (2013) ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE/Abeta association in physiological conditions. Proc Natl Acad Sci USA 110:E1807-E1816. doi:10.1073/pnas.1220484110
-
(2013)
Proc Natl Acad Sci USA
, vol.110
-
-
Verghese, P.B.1
Castellano, J.M.2
Garai, K.3
-
48
-
-
83455230813
-
Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer's disease: A systematic review and meta-analysis
-
doi:10.1159/000334607
-
Ward A, Crean S, Mercaldi CJ et al (2012) Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer's disease: a systematic review and meta-analysis. Neuroepidemiology 38:1-17. doi:10.1159/000334607
-
(2012)
Neuroepidemiology
, vol.38
, pp. 1-17
-
-
Ward, A.1
Crean, S.2
Mercaldi, C.J.3
-
49
-
-
84872189834
-
Low CSF levels of both alpha-synuclein and the alpha-synuclein cleaving enzyme neurosin in patients with synucleinopathy
-
doi:10.1371/journal.pone.0053250
-
Wennstrom M, Surova Y, Hall S et al (2013) Low CSF levels of both alpha-synuclein and the alpha-synuclein cleaving enzyme neurosin in patients with synucleinopathy. PLoS ONE 8:e53250. doi:10.1371/journal.pone.0053250
-
(2013)
PLoS ONE
, vol.8
-
-
Wennstrom, M.1
Surova, Y.2
Hall, S.3
-
50
-
-
84861896052
-
In vivo human apolipoprotein E isoform fractional turnover rates in the CNS
-
doi:10.1371/journal.pone.0038013
-
Wildsmith KR, Basak JM, Patterson BW et al (2012) In vivo human apolipoprotein E isoform fractional turnover rates in the CNS. PLoS ONE 7:e38013. doi:10.1371/journal.pone.0038013
-
(2012)
PLoS ONE
, vol.7
-
-
Wildsmith, K.R.1
Basak, J.M.2
Patterson, B.W.3
-
51
-
-
84876136764
-
Cerebrovascular effects of apolipoprotein E: Implications for Alzheimer disease
-
doi:10.1001/jamaneurol.2013.2152
-
Zlokovic BV (2013) Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease. JAMA Neurol 70:440-444. doi:10.1001/ jamaneurol.2013.2152
-
(2013)
JAMA Neurol
, vol.70
, pp. 440-444
-
-
Zlokovic, B.V.1
|